Hoth Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-7.85	-11.37	-14.28	-7.2	-7.7	-2.5
Depreciation & Amortization	0	0	0	0	0	0
Share-Based Compensation	0.22	0.62	1.32	0.74	2.5	0.14
Other Operating Activities	-0.82	1.45	0.87	0.33	0.26	0.25
Operating Cash Flow	-8.45	-9.3	-12.09	-6.13	-4.95	-2.1
Acquisitions	0	0	0	-0.46	0	0
Change in Investments	0	1.24	-0.05	-1.21	-0.8	0
Other Investing Activities	-	-0.07	-0.12	-0.17	-0.1	-
Investing Cash Flow	0	1.16	-0.17	-1.84	-0.9	0
Share Issuance / Repurchase	11.32	5.99	18.19	8.73	7.45	0
Other Financing Activities	-	0.05	-	-	-	1.15
Financing Cash Flow	11.32	6.04	18.19	8.73	7.45	1.15
Exchange Rate Effect	-0.01	-0.01	-0.03	-0.02	0	0
Net Cash Flow	2.87	-2.1	5.94	0.75	1.61	-0.95
Free Cash Flow	-8.45	-9.3	-12.09	-6.13	-4.95	-2.1
Free Cash Flow Per Share	-2.48	-7.76	-13.54	-12.40	-13.49	-10.45

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).